The post-pandemic biotech opportunity

von Tobias Thieme · 06.03.2021

Green Deal: Surveys show that despite COVID-19, climate change and sustainability still matter to consumers – perhaps even more than ever before. The European Commission has proposed investing more than a third of the €750bn earmarked for its ‘NextGenerationEU’ post-COVID-19 recovery programme into building a sustainable economy. Along with the well-established ‘red’ biotech sector in healthcare, green biotech companies also stand to benefit significantly.